540
Views
2
CrossRef citations to date
0
Altmetric
Nose/Sinus

Human papillomavirus and infiltration of CD8- and Foxp3-positive immune cells in sinonasal inverted papillomas

, , , , &
Pages 1019-1023 | Received 07 May 2019, Accepted 30 Jul 2019, Published online: 05 Sep 2019

References

  • Buchwald C, Franzmann MB, Tos M. Sinonasal papillomas: a report of 82 cases in Copenhagen County, including a longitudinal epidemiological and clinical study. Laryngoscope. 1995;105:72–79.
  • Healy DY, Jr., Chhabra N, Metson R, et al. Surgical risk factors for recurrence of inverted papilloma. Laryngoscope 2016;126:796–801.
  • d'Errico A, Zajacova J, Cacciatore A, et al. Occupational risk factors for sinonasal inverted papilloma: a case-control study. Occup Environ Med. 2013;70:703–708.
  • Syrjanen K, Syrjanen S. Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis. Laryngoscope. 2013;123:181–192.
  • Jenko K, Kocjan B, Zidar N, et al. In inverted papillomas HPV more likely represents incidental colonization than an etiological factor. Virchows Arch. 2011;459:529–538.
  • Hoffmann M, Quabius ES, Tribius S, et al. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO2-laser surgery plus risk adapted therapy – a 10 year retrospective single centre study. Cancer Lett. 2018;413:59–68.
  • Kim SG, Lee OY, Choi JW, et al. Pattern of expression of cell cycle-related proteins in malignant transformation of sinonasal inverted papilloma. Am J Rhinol Allergy. 2011;25:75–81.
  • Wang MJ, Noel JE. Etiology of sinonasal inverted papilloma: a narrative review. World J Otorhinolaryngol Head Neck Surg. 2017;3:54–58.
  • Seo N, Shirakura Y, Tahara Y, et al. Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells. Nat Commun. 2018;9:435.
  • Nordfors C, Grun N, Tertipis N, et al. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer 2013;49:2522–2530.
  • Shah W, Yan X, Jing L, et al. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell Mol Immunol. 2011;8:59–66.
  • Marklund L, Nasman A, Ramqvist T, et al. Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer. Cancer Med. 2012;1:82–88.
  • Nasman A, Romanitan M, Nordfors C, et al. Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 2012;7:e38711.
  • Rooper LM, Bishop JA, Westra WH. Transcriptionally active high-risk human papillomavirus is not a common etiologic agent in the malignant transformation of inverted schneiderian papillomas. Head Neck Pathol. 2017;11:346–353.
  • Kilic S, Kilic SS, Kim ES, et al. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2017;7:980–989.
  • Sham CL, To KF, Chan PK, et al. Prevalence of human papillomavirus, Epstein-Barr virus, p21, and p53 expression in sinonasal inverted papilloma, nasal polyp, and hypertrophied turbinate in Hong Kong patients. Head Neck. 2012;34:520–533.
  • Hoffmann M, Kahn T, Goeroegh T, et al. Tracing human papillomavirus DNA in nasal polyps by polymerase chain reaction. Acta Otolaryngol. 2000;120:872–875.
  • Zhao L, Li CW, Jin P, et al. Histopathological features of sinonasal inverted papillomas in chinese patients. Laryngoscope 2016;126:E141–E147.
  • Nygren A, Kiss K, von Buchwald C, et al. Rate of recurrence and malignant transformation in 88 cases with inverted papilloma between 1998-2008. Acta Otolaryngol. 2016;136:333–336.
  • Elliot A, Marklund L, Hakansson N, et al. Incidence of IP and risk of malignant transformation in the Swedish population 1960-2010. European Arch Otorhinolaryngol. 2017;274(3):1445–1448.